Sharp John P - Insider Stock Trading - OpenInsider

CIK: 1342894 - Address: C/o Phasebio Pharmaceuticals, Inc., 1 Great Valley Parkway, Suite 30, Malvern, PA 19355

15 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
S	%ret	1	1	5	-1	3	7	26	22	1	10
S	%wins				100	40	40	20	20	20	40

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
11/3/21 19:30	11/3/21	PHAS	Phasebio Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	PA	O	CFO	M.d	13	1.68	0	8	15	58	D
9/3/21 16:41	8/3/21	PHAS	Phasebio Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	PA	O	CFO	M.ad	13	1.68	0	8	18	50	D
8/17/20 20:15	8/14/20	PHAS	Phasebio Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	PA	O	CFO	M.d	8	1.69	0	5	14	40	D
8/22/19 19:42	8/21/19	PHAS	Phasebio Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	PA	O	CFO,Secr	M.d	24	1.61	0	15	75	35	D
5/24/19 14:22	5/22/19	PHAS	Phasebio Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	PA	O	CFO,Secr	M.d	25	1.69	0	15	300	20	D
12/11/18 16:16	12/7/18	PHAS	Phasebio Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	PA	O	CFO,Secr	P	19	3.84	0	5	New	5	D
2/14/14 20:18	2/12/14	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	M.d	1,528	17.57	26	87		18	D	438	281	80	63	54	31	33	26	-4	-3	0	-16	-28	-27
2/14/14 20:18	2/12/14	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	S.d	-6,499	74.74	26	-87	-83	18	D	438	281	80	63	54	31	33	26	-4	-3	0	-16	-28	-27
12/16/13 17:09	12/12/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	M.d	7	9.96	27	1	4	18	D	344	180	67	12	1	-2	-5	-3	0	7	22	53	23	1
12/16/13 17:09	12/12/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	S.d	-37	53.44	27	-1	-4	18	D	344	180	67	12	1	-2	-5	-3	0	7	22	53	23	1
12/9/13 18:53	12/6/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	S	-336	56.08	27	-6	-25	18	D	356	199	69	12	-5	3	-6	1	0	-3	3	31	28	3
11/20/13 18:49	11/18/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	M.d	6	9.96	17	1	3	24	D	375	177	93	21	18	-3	9	8	-3	8	0	40	22	1
11/20/13 18:49	11/18/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	S.d	-60	53.00	17	-1	-5	24	D	375	177	93	21	18	-3	9	8	-3	8	0	40	22	1
8/20/13 18:44	8/16/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	M.d	75	9.96	10	8	45	24	D	243	158	100	55	-1	-10	0	-3	0	5	8	21	67	27
8/20/13 18:44	8/16/13	LGND	Ligand Pharmaceuticals Inc	DE	Health	Drug	Pharmaceutical Preparations	Sharp John P	CA	O	VP Finan	S.d	-321	42.75	10	-8	-24	24	D	243	158	100	55	-1	-10	0	-3	0	5	8	21	67	27

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact